Filing Details

Accession Number:
0001415889-22-011878
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-01 16:16:00
Reporting Period:
2022-11-29
Accepted Time:
2022-12-01 16:16:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1730430 Kiniksa Pharmaceuticals Ltd. KNSA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1384243 D Barry Quart C/O Kiniksa Pharmaceuticals, Ltd.
Clarendon House 2 Church Street
Hamilton D0 HM 11
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Share Acquisiton 2022-11-29 21,959 $1.59 21,959 No 4 M Direct
Class A Common Share Disposition 2022-11-29 21,959 $16.15 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Share Share Option Disposition 2022-11-29 21,959 $0.00 21,959 $1.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-12-15 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $16.09 to $16.25. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Class A Common Shares sold at each price.
  2. The option is fully vested and exercisable.